The Burden of Psoriasis:

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US.

Introduction

Psoriasis and Comorbid Disease

Psoriasis Is Undertreated

Barriers to the Treatment of Psoriasis

Goals for Therapy

Treating to Target

The Psychiatric Burden of Psoriasis

Psoriasis and Its Impact on QoL Emotional Toll

Psoriasis and Its Impact on QoL Economic Toll

Assessing QoL in Patients With Psoriasis

Starting the Conversation About Depression

Dermatologist and PCP Comanagement

Multidisciplinary Partnerships

The Patient as a Partner

Psoriasis Treatment and Its Effect on Outcomes: Efficacy

Psoriasis Treatment and Its Effect on Outcomes: Psychosocial Issues

Take-Home Points

Abbreviations